Table 2.
Distribution of conditions pertaining to nine studies and associated treatments based on a mixture of two components for the Actin gene sub-network.
| Condition | |||||||||
| Series: | 68 | 69 | 70 | 72 | 74 | 75 | 76 | 77 | 79 |
| Mix1 | 5 | 1 | 4 | 2 | 4 | 5 | 7 | 1 | 6 |
| Mix2 | 0 | 3 | 0 | 5 | 9 | 0 | 0 | 6 | 0 |
| Treatment: | cnt | mhg | CdA | eth | Ro | PK | Oxg | ||
| Mix1 | 3 | 11 | 10 | 2 | 3 | 5 | 5 | ||
| Mix2 | 7 | 7 | 3 | 8 | 4 | 6 | 0 | ||
Studies: Gene Expression Omnibus series 1068, 1069, 1070, 1072, 1074, 1075, 1076, 1077, 1079.
Treatments: control or cnt, methylmercury or mhg, ethanol or eth, 2-chloro-2'deoxyadenosine or CdA, oxygen or oxg, PK11195 or PK, and Ro5-4864 or Ro. Mix1 and Mix2: mixture components 1 and 2 respectively.
Genes in sub-network: Actin, RhoA, Afadin, α-Catenin, Vinculin, α-Actinin, and ZO-1.